CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 4 of 11

Lupus Science & Medicine

Briefs 121–160 of 423 CurrentRheuma has covered from this journal, newest publication first

Latest from Lupus Science & Medicine

All coverage, newest first

  1. Lupus Sci Med

    Serum IL-2 levels are associated with disease activity and related to dyslipidaemia and the immunological profile in systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  2. Lupus Sci Med

    Biomarker-stratified efficacy and safety of biologics in systemic lupus erythematosus: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  3. Lupus Sci Med

    Clinical utility and performance of anti-C1q antibodies for SLE: comparative analysis of three different assays

    Cross-sectional studyLupus & APS

  4. Lupus Sci Med

    High incidence of herpes zoster among SLE patients in Indonesia: a retrospective cohort study

    Cohort studyLupus & APS

  5. Lupus Sci Med

    Sex-based clinical and immunological differences across lupus erythematosus subtypes: a cross-sectional multicentre study from China

    Cross-sectional studyLupus & APS

  6. Lupus Sci Med

    Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes

    Cohort studyLupus & APS

  7. Lupus Sci Med

    Induction treatment of lupus nephritis: to pulse or not to pulse? Whether ’tis nobler to universally or selectively prescribe

    Research articleLupus & APS

  8. Lupus Sci Med

    Statin therapy in systemic lupus erythematosus: a meta-analysis of disease activity and inflammatory biomarkers

    Meta-analysisLupus & APS

  9. Lupus Sci Med

    Fracture risk tools performance and potential use in systemic lupus erythematosus

    Secondary analysisOsteoporosis

  10. Lupus Sci Med

    Serum S100A8 as a potential biomarker for diagnosis of antiphospholipid syndrome and risk stratification among aPL carriers

    Diagnostic or prognostic studyLupus & APS

  11. Lupus Sci Med

    Trajectories of long-term eGFR and proteinuria in lupus nephritis: a real-world biopsy-proven cohort study

    Cohort studyLupus & APS

  12. Lupus Sci Med

    Alterations in the DTI-ALPS index and choroid plexus volume as brain–immune interfacing indicators in neuropsychiatric lupus erythematosus with inflammatory phenotype

    Cross-sectional studyLupus & APS

  13. Lupus Sci Med

    Malignancies in lupus nephritis: a retrospective cohort study on epidemiology and risk factors

    Cohort studyLupus & APS

  14. Lupus Sci Med

    Regulatory dynamics of IFI44L in systemic lupus erythematosus: the interplay of type I interferon and c-Jun

    Mechanistic studyLupus & APS

  15. Lupus Sci Med

    Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry

    Cohort studyLupus & APS

  16. Lupus Sci Med

    Balancing stringency and feasibility: comparative value of disease-activity measures to predict pregnancy outcomes in systemic lupus erythematosus

    Cohort studyLupus & APS

  17. Lupus Sci Med

    Telitacicept versus belimumab for the treatment of systemic lupus erythematosus: a network meta-analysis and cost-effectiveness analysis

    Meta-analysisLupus & APS

  18. Lupus Sci Med

    Clinical value of simultaneous detection of anti-dsDNA and anti-chromatin antibodies using a multiplex immunoassay in systemic lupus erythematosus: a 5-year retrospective study

    Cohort studyLupus & APS

  19. Lupus Sci Med

    Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review

    Research article

  20. Lupus Sci Med

    Age-related patterns of organ damage impact on health-related quality of life in SLE

    Cross-sectional studyLupus & APS

  21. Lupus Sci Med

    Association between disease duration and comorbidity burden in systemic lupus erythematosus: a multicentre study from Pakistan

    Cross-sectional studyLupus & APS

  22. Lupus Sci Med

    Systemic lupus erythematosus comorbid with chronic spontaneous urticaria: a multicentre retrospective study

    Case-control studyLupus & APS

  23. Lupus Sci Med

    Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality

    Cohort studyLupus & APS

  24. Lupus Sci Med

    Combining mepacrine with hydroxychloroquine-based therapy in active systemic lupus erythematosus: an observational study of 106 patients from the Lupus-Cruces cohort

    Cohort studyLupus & APS

  25. Lupus Sci Med

    Burden of herpes zoster among patients with systemic lupus erythematosus in the USA

    Cohort studyLupus & APS

  26. Lupus Sci Med

    Function of follicular helper 17 T cells in driving B cells for anti-DNA autoantibody production in patients with SLE

    Mechanistic studyLupus & APS

  27. Lupus Sci Med

    Risk factors and outcomes of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a retrospective-multicentre cohort study and systematic literature review

    Cohort studyLupus & APS

  28. Lupus Sci Med

    Proteomic analysis reveals angiogenesis-related plasma proteins associated with pre-eclampsia in SLE

    Cohort studyLupus & APS

  29. Lupus Sci Med

    New efforts to incorporate patient-reported outcomes into lupus clinical trials: report of the community meeting convened by the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), 16–17 October 2024

    Guideline or statementLupus & APS

  30. Lupus Sci Med

    Complete blood count-derived biomarkers as indicators of systemic lupus erythematosus activity: a cross-sectional comparative study

    Cross-sectional studyLupus & APS

  31. Lupus Sci Med

    Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity

    Diagnostic or prognostic studyLupus & APS

  32. Lupus Sci Med

    Inflammation in areas of fibrosis precedes loss of kidney function in lupus nephritis

    Cohort studyLupus & APS

  33. Lupus Sci Med

    Prevalence and predictive factors associated with sustained remission in SLE: a systematic review

    Meta-analysisLupus & APS

  34. Lupus Sci Med

    Dietary Intervention for Systemic Lupus Erythematosus patients based on HLA-DQ2 and DQ8 genotyping (DISH): a protocol for a randomised controlled study

    Trial designLupus & APS

  35. Lupus Sci Med

    Development and validation of nomograms for predicting activity index and tubulointerstitial lesions in lupus nephritis: a multicentre study

    Diagnostic or prognostic studyLupus & APS

  36. Lupus Sci Med

    Phenotypically driven subgroups of primary antiphospholipid syndrome-associated thrombocytopenia display distinct outcomes: a prospective cohort study with cluster analysis

    Cohort studyLupus & APS

  37. Lupus Sci Med

    Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study

    Cohort studyLupus & APS

  38. Lupus Sci Med

    Cardiovascular magnetic resonance as an initial screening tool in individuals with SLE and chest pain

    Cross-sectional studyLupus & APS

  39. Lupus Sci Med

    Real-world immune response to SARS-CoV-2 vaccination in Thai patients with systemic lupus erythematosus: a cross-sectional observational study

    Cross-sectional studyLupus & APS

  40. Lupus Sci Med

    Proteins upregulated in thrombotic antiphospholipid syndrome linked to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews

    Meta-analysisLupus & APS

All 423 Briefs in ExploreShowing Briefs 121–160 of 423, newest first